A Novel Nomogram for Identifying Candidates for Adjuvant Chemotherapy in Patients With Stage IB Non-small Cell Lung Cancer

BACKGROUND: This study aimed to develop a novel predictive nomogram to identify specific stage IB non-small cell lung cancer (NSCLC) populations who could benefit from adjuvant chemotherapy (ACT). METHOD: Stage IB NSCLC patients were included in the Surveillance, Epidemiology, and End Results (SEER)...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xue, Xie, Yangyang, Deng, Haoran, Yu, Fei, Wang, Shiqiang, Lou, Yafang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201645/
https://www.ncbi.nlm.nih.gov/pubmed/37204026
http://dx.doi.org/10.1177/10732748231177541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201645/
https://www.ncbi.nlm.nih.gov/pubmed/37204026
http://dx.doi.org/10.1177/10732748231177541

Ejemplares similares